AngioDynamics, Inc. (ANGO)

Revenue by Segment

Financials in millions USD. Fiscal year is June - May.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020	May 31, 2019	May 31, 2018	May 31, 2017
Med Tech	149.95M	126.65M	106.40M	96.69M	78.72M
Med Device	170.22M	165.85M	197.51M	242.07M	237.50M
Total	320.17M	292.50M	303.91M	338.75M	316.22M

Revenue by Geography

Financials in millions USD. Fiscal year is June - May.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020	May 31, 2019	May 31, 2018	May 31, 2017
United States	274.92M	250.98M	251.49M	282.71M	265.96M
International	45.25M	41.52M	52.43M	56.04M	50.26M
Total	320.17M	292.50M	303.91M	338.75M	316.22M

Data Source: S&P Global Market Intelligence Last updated: Jul 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 22, 2026

Data Sources Report a data error